U.S. Oil and Gas Stock News

PPL (PPL) is drawing investor attention after outlining a planned US$23 billion investment program through 2029, supported by disciplined cost management and closely tied to its current earnings guidance. See our latest analysis for PPL. Despite the fresh US$23 billion investment plan and grid upgrade story, PPL's recent momentum has softened, with the share price down over the past quarter. However, the 3 year total shareholder return of 40.04% and 5 year total shareholder return of 47.30%...

Progyny stock has climbed 40.3% over the past year, and investors now face a clear split between valuation signals, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to around 50% upside while market multiples suggest the shares screen as expensive. Over the last 12 months, Progyny has delivered a 40.3% return, which puts more pressure on today’s buyers to judge whether that performance already reflects the good news in the price. Recent analyst upgrades tied to stronger...

Boston Scientific stock is coming off a difficult stretch, with the share price down 58.1% over the past year, yet the broader valuation checks still lean toward the stock looking inexpensive relative to its fundamentals. That gap between weak recent returns and a stronger value profile is what current and prospective holders are trying to make sense of. Over the past 1 year, Boston Scientific has declined 58.1%, which puts recent sentiment under pressure even as longer term holders reassess...

Recent Trading Context For CRISPR Therapeutics Stock CRISPR Therapeutics (NasdaqGM:CRSP) has been trading with mixed short term moves, rising about 2.5% over the past day while declining around 4.6% over the past week and 11% over the past month. See our latest analysis for CRISPR Therapeutics. At a share price of $48.15, CRISPR Therapeutics has seen short term share price pressure, with the 30 day share price return down 10.98% and the year to date share price return down 10.45%, alongside a...

CME Group stock has given investors a solid 5 year return, yet current checks suggest it is not obviously cheap, with the Excess Returns intrinsic value estimate sitting close to the market price while earnings based multiples point to a premium. CME Group has returned about 37% over the past 5 years, which is respectable but not a runaway result that clearly justifies paying any price. New product launches such as Treasury Link and expanded agriculture contracts can support long term fee...

In July 2026, Instacart and Tractor Supply Company announced a nationwide partnership to offer same-day delivery from more than 2,400 Tractor Supply stores, giving rural customers app-based access to a wide mix of pet, livestock, hardware, and garden products in as little as one hour with no markups. This move extends on-demand e-commerce into many small communities that are often far from urban retail hubs, potentially reshaping how Tractor Supply’s core rural customers purchase everyday...

Sunoco (NYSE:SUN) has closed a $275 million shelf registration tied to the issuance of 10,000,000 common units. The offering is connected to an Employee Stock Ownership Plan and affects how equity is allocated to employees. The closure finalizes a capital markets move that may influence Sunoco's capital structure and ownership mix. For investors tracking Sunoco, the completion of this ESOP related shelf registration comes at a time when the stock trades around $74.99 and has produced strong...

AI small caps are attracting fresh attention as investors look beyond large tech stocks and search for earlier stage opportunities tied to machine learning, automation, and data intelligence. With inflation, interest rates, and energy costs shaped by Middle East tensions and shifting policy across major economies, many readers are looking for targeted ways to back companies directly focused on AI progress. This AI Small Caps screener is designed to highlight smaller companies that are focused...

Silicon Motion Technology stock has delivered a very strong three year return, yet the broader valuation checks lean expensive, which raises questions about how much optimism is already reflected in the current price of US$278.17. Over the last three years, Silicon Motion Technology has returned about 4.8x an initial investment, which sets a high bar for what needs to go right from here to justify that performance. Expansion into areas such as AI infrastructure and automotive storage can...

Definium Therapeutics stock has delivered a very large 3 year gain, yet the valuation checks and current market pricing now point to a more cautious picture, with the shares screening as expensive on traditional multiples. Over the past 3 years, Definium Therapeutics has returned about 9.2x, which sets a high bar for any further upside to be justified by fundamentals. Positive Phase 3 data for DT120 in depression and the recent US$805m capital raise can support expectations for future...

Earlier this week, Bloom Energy announced a US$1.70 billion fuel cell deployment for a Nebius AI cloud data center and highlighted an expanded Brookfield power financing partnership focused on AI infrastructure. These deals underscore how Bloom’s solid-oxide fuel cells are increasingly being positioned as an on-site power solution for energy-hungry AI data centers facing grid bottlenecks. Against this backdrop of a very large AI data center power commitment, we’ll examine how the news could...

Allient stock has returned about 180% over the past five years. Yet at around US$89.97 per share, both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiple checks currently point to the shares trading at a premium rather than as an obvious bargain. Over five years, a roughly 180% share price gain suggests early investors have already seen strong compounding. This can limit the margin of safety for anyone considering the stock today. Future cash flow growth and the...

Axon Enterprise, Inc. recently appointed Vivek Mohindra and Eiso Kant as independent directors, with Mohindra joining the Audit and Compensation Committees and Kant serving as a non-voting observer on the M&A and Capital Structure Committee. The combination of Mohindra’s enterprise and hardware experience and Kant’s AI and infrastructure background brings added depth to Axon’s push toward connected, software-driven public safety solutions. We’ll now examine how these board appointments,...

AppLovin (APP) is back in focus after a disputed short-seller report and rising competition in AI-powered advertising, with management emphasizing profit margins, stock buybacks, and its expanding monetization platform to influence sentiment. See our latest analysis for AppLovin. The recent short seller dispute and rising AI ad competition have played into AppLovin’s sharp share price reset, with the stock down 30.67% on a year to date share price return and 8.73% over 30 days, even as the 1...

In recent days, United Parcel Service (UPS) has faced increased scrutiny ahead of its now-past Q2 2026 earnings release, as analysts weighed expectations for higher revenue and modest earnings growth against evolving parcel pricing trends and shifting fuel surcharges. At the same time, rising delivery costs and Amazon Shipping’s more aggressive pricing have highlighted how quickly competition can reshape UPS’s parcel economics and bargaining power with customers. We’ll now examine how...

Why Universal Health Services stock is in focus Universal Health Services (UHS) is back on investors radar after two recent corporate moves: a new delayed draw term loan facility of up to $700 million and a reaffirmed quarterly cash dividend. See our latest analysis for Universal Health Services. At a share price of $149.91, Universal Health Services has seen its 7 day share price return rise 3.94% and its 30 day share price return rise 6.19%. However, the 90 day share price return has fallen...

Norfolk Southern recently faced two significant developments: analyst expectations for Q2 2026 earnings and revenue, and new lawsuits alleging long-term worker exposure to toxic substances and safety violations under the Federal Employers' Liability Act. Together, shifting earnings estimates and mounting legal claims highlight how operational performance and potential liability risks are becoming increasingly intertwined for the railroad operator. Next, we'll examine how renewed Q2 earnings...

General Dynamics stock has more than doubled over the past five years, and yet both its Discounted Cash Flow (DCF) intrinsic value estimate and earnings based multiples currently point to the shares trading at a discount rather than a premium. That combination, alongside mixed signals from the broader valuation checks, is what investors now have to weigh. A 110.5% return over five years suggests General Dynamics has already rewarded patient shareholders, so any further upside needs to be...

L3Harris Technologies recently announced a U.S. Space Force contract to build 18 Accelerated Missile Defense Tranche 3 satellites and separate U.S. Army orders totaling US$84 million for Next Generation Command and Control manpack Falcon systems, underscoring its role in missile tracking and secure battlefield communications. The new space and communications awards build on earlier hypersonic tracking successes and more than 70 missile defense satellites now on order, highlighting how...

UnitedHealth Group stock has delivered a strong 57.1% return over the past year, and the current valuation checks now point to a mixed picture rather than an obvious bargain or clear overpricing. Over the last 12 months, a 57.1% gain has pushed UnitedHealth Group firmly back into focus for investors weighing how much of the recovery is already reflected in the share price. Recent earnings strength and operational improvements can support expectations for healthier margins, while the expanded...

Dynex Capital (DX) opened Q2 2026 with total revenue of US$197.0 million and basic EPS of US$0.80, alongside trailing 12 month revenue of US$502.3 million and EPS of US$2.38 that frame the latest quarterly print. The company has seen revenue move from US$107.8 million on a trailing basis in Q1 2025 to US$502.3 million by Q2 2026, with EPS over the same window shifting from US$0.80 to US$2.38, giving investors a clearer read on how the earnings line has tracked headline revenue. Together with...

BlackLine's share price has fallen a long way over the past few years. Yet at around US$29.36, and with a weak overall value score, the stock still screens as expensive on traditional valuation checks rather than as a clear bargain. Over the past 5 years, BlackLine shareholders have seen the stock decline about 74%, which places the current valuation in the context of a prolonged period of weak returns. For the current price to hold up, investors may be counting on BlackLine to translate its...

Recent Moves in AtriCure Stock AtriCure (ATRC) has drawn attention after a recent stretch of positive returns over the past month and past 3 months, prompting investors to reassess how the stock currently prices its medical device business. See our latest analysis for AtriCure. Viewed over a longer stretch, AtriCure’s recent 30 day share price return of 19.81% and 90 day share price return of 24.88% sit against a year to date share price decline of 12.13% and a 1 year total shareholder return...

Netflix stock has fallen sharply over the past year. However, on current checks it still screens as cheap, with both earnings multiples and an intrinsic value estimate pointing to more value than the market is currently pricing in. Over the past 3 years, Netflix has delivered a 60.6% gain, which suggests the longer term story has rewarded investors even though recent returns have been weak. New revenue streams from advertising and live sports can support the cash flow outlook. At the same...